November 24, 2020
In today's episode of HIMSSCast, guest host Laura Lovett, managing editor of MobiHealthNews, checks in with Maria Velissaris, founding partner at Steel Sky Ventures and Colette Courtion, founder and CEO of Joylux about some of the challenges facing the burgeoning women's health and reproductive health, or femtech, industry. In particular, they chat about advertising double standards, funding...
November 19, 2020
The femtech world is beginning to venture out of the boundaries of reproductive health and into other areas of women’s health, according to panelists at Bayer G4A summit yesterday.
Over the summer, Rock Health report that about 65% of all femtech funding has gone into fertility, pregnancy or motherhood. Today innovators are looking beyond the reproductive umbrella, at how technology and research...
November 13, 2020
Virtual fertility clinic, Apricity has launched an online fertility predictor tool designed to predict a woman's chances of conceiving naturally based on information input about her lifestyle choices.
The tool combines a woman’s age with questions about her lifestyle choices via a short quiz in order to predict her chances of conceiving naturally, with the result displayed as a percentage.
October 27, 2020
London-based femtech company, Clementine has nabbed £1 million of funding from investors Fortunis Capital, to expand on its goal of improving the emotional wellbeing of women.
The femtech company provides virtual hypnotherapy sessions and wellness products to empower women to feel more confident.
WHY IT MATTERS
COVID-19 has had a disproportionate effect on the mental wellness of women. Evidence...
October 20, 2020
Swedish CE-certified birth control app, Natural Cycles has announced that it has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA).
The Natural Cycles app, is the first and only FDA cleared birth control app in the US.
WHY IT MATTERS
The purpose of the notification is to revise the labeling to expand the third-party thermometers, which include wearables...
August 28, 2020
Women’s health startups are starting to garner a lot of attention. However, a new report out of PitchBook found that the industry is still struggling to catch the attention of VCs, and has produced few exits.
“Only six femtech exits were completed in 2019; however, this still represents a 64% increase in exit value compared to 2018. The largest exits in recent years include Progyny’s (NASDAQ:...
August 24, 2020
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
August 11, 2020
Nurx, a startup known for online purchase and delivery of home health tests, birth control and other sensitive treatments for women, has tacked on another $22.5 million in Series C funding.
Closed in May, the raise included new backers Trustbridge, Comcast Ventures and Wittington Ventures, as well as prior backers Union Square Ventures and Kleiner Perkins Digital Growth Fund. This brings the...
Photo credit: Clue Health
July 20, 2020
Berlin-based Clue was one of the early companies in the femtech world. Founded in 2012, to date it has raised just under $30 million. Today it named Dr. Lynae Brayboy its first chief medical officer.
A trained OBGYN, with a specialty in reproductive endocrinology and fertility, Brayboy has a long history of working in women’s health and a track record of studying femtech products.
“When I was...
January 14, 2020
The femtech business is making its way onto the digital health map. In fact, according to a new market report by Research2Guidance, there are now over 3,000 app-based women’s health products on the market.
“The addressable market is huge and so we think that the market is still very much in the beginning,” Ralf Jahns, managing director of Reasearch2Guidance, told MobiHealthNews.